The latest closing stock price for Neumora Therapeutics as of November 20, 2024 is 9.79.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-398 today, roughly 0 times their original investment - a -39.75% compound annual growth rate over 1 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 21.00, which is 114.5% above the current share price.
The Neumora Therapeutics 52-week low stock price is 8.33, which is 14.9% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 12.88.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-398 today, roughly 0 times their original investment - a -39.75% compound annual growth rate over 1 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 21.00, which is 114.5% above the current share price.
The Neumora Therapeutics 52-week low stock price is 8.33, which is 14.9% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 12.88.